FI20075498A - Menetelmä amblyopian hoitamiseksi masennuslääkkeillä - Google Patents

Menetelmä amblyopian hoitamiseksi masennuslääkkeillä

Info

Publication number
FI20075498A
FI20075498A FI20075498A FI20075498A FI20075498A FI 20075498 A FI20075498 A FI 20075498A FI 20075498 A FI20075498 A FI 20075498A FI 20075498 A FI20075498 A FI 20075498A FI 20075498 A FI20075498 A FI 20075498A
Authority
FI
Finland
Prior art keywords
antidepressants
procedure
treating amblyopia
amblyopia
treating
Prior art date
Application number
FI20075498A
Other languages
English (en)
Swedish (sv)
Other versions
FI20075498A0 (fi
Inventor
Eero Castren
Lamberto Maffei
Vetencourt Jose Maya
Original Assignee
Eero Castren
Lamberto Maffei
Vetencourt Jose Maya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eero Castren, Lamberto Maffei, Vetencourt Jose Maya filed Critical Eero Castren
Priority to FI20075498A priority Critical patent/FI20075498A/fi
Publication of FI20075498A0 publication Critical patent/FI20075498A0/fi
Priority to AU2008270231A priority patent/AU2008270231B2/en
Priority to US12/306,798 priority patent/US8133906B2/en
Priority to PCT/FI2008/050392 priority patent/WO2009004114A1/en
Priority to JP2010514023A priority patent/JP2010531858A/ja
Priority to CA 2692448 priority patent/CA2692448A1/en
Priority to EP08775517A priority patent/EP2173334A4/en
Publication of FI20075498A publication Critical patent/FI20075498A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI20075498A 2007-06-29 2007-06-29 Menetelmä amblyopian hoitamiseksi masennuslääkkeillä FI20075498A (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20075498A FI20075498A (fi) 2007-06-29 2007-06-29 Menetelmä amblyopian hoitamiseksi masennuslääkkeillä
AU2008270231A AU2008270231B2 (en) 2007-06-29 2008-06-27 A method of treating amblyopia
US12/306,798 US8133906B2 (en) 2007-06-29 2008-06-27 Method of treating amblyopia
PCT/FI2008/050392 WO2009004114A1 (en) 2007-06-29 2008-06-27 A method of treating amblyopia
JP2010514023A JP2010531858A (ja) 2007-06-29 2008-06-27 弱視の治療方法
CA 2692448 CA2692448A1 (en) 2007-06-29 2008-06-27 A method of treating amblyopia
EP08775517A EP2173334A4 (en) 2007-06-29 2008-06-27 METHOD OF TREATING AMBLYOPIA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20075498A FI20075498A (fi) 2007-06-29 2007-06-29 Menetelmä amblyopian hoitamiseksi masennuslääkkeillä

Publications (2)

Publication Number Publication Date
FI20075498A0 FI20075498A0 (fi) 2007-06-29
FI20075498A true FI20075498A (fi) 2008-12-30

Family

ID=38212469

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20075498A FI20075498A (fi) 2007-06-29 2007-06-29 Menetelmä amblyopian hoitamiseksi masennuslääkkeillä

Country Status (7)

Country Link
US (1) US8133906B2 (fi)
EP (1) EP2173334A4 (fi)
JP (1) JP2010531858A (fi)
AU (1) AU2008270231B2 (fi)
CA (1) CA2692448A1 (fi)
FI (1) FI20075498A (fi)
WO (1) WO2009004114A1 (fi)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1336490C (en) 1988-06-03 1995-08-01 Paul Michael Iuvone Pharmacological treatment of ocular development
US5461052A (en) * 1993-04-30 1995-10-24 The Trustees Of The University Of Pennsylvania Prevention of myopia by tricyclic compounds
US5385939A (en) 1993-04-30 1995-01-31 The Trustees Of The University Of Pennsylvania GABA-ergic modulation of eye growth
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent
US6876758B1 (en) * 1999-12-27 2005-04-05 Neuro Vision, Inc. Methods and systems for improving a user's visual perception over a communications network
MXPA02007039A (es) 2000-01-18 2003-09-25 Univ Pennsylvania Crecimiento ocular y antagonistas nicotinicos.
US20060264508A1 (en) 2001-10-16 2006-11-23 Stone Richard A Modulation of ocular growth and myopia by gaba drugs
US6692481B2 (en) * 2001-12-13 2004-02-17 John M. Guerrero Method and apparatus for treatment of amblyopia

Also Published As

Publication number Publication date
JP2010531858A (ja) 2010-09-30
US8133906B2 (en) 2012-03-13
EP2173334A4 (en) 2010-06-30
FI20075498A0 (fi) 2007-06-29
AU2008270231A1 (en) 2009-01-08
CA2692448A1 (en) 2009-01-08
EP2173334A1 (en) 2010-04-14
US20100093805A1 (en) 2010-04-15
AU2008270231B2 (en) 2013-06-27
WO2009004114A1 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
BRPI0910854A2 (pt) métodos de tratamento
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
BRPI0923912A2 (pt) aparelho de cateter.
BRPI0920104A2 (pt) tratamento de soluções ou de águas residuais
DK2405869T3 (da) Fedmebehandling
BRPI0916125A2 (pt) &#34;dispositivo de tratamento&#34;
BRPI0910259A2 (pt) métodos de tratamento de inflamação
PL2128324T3 (pl) Traktowanie tekstyliów
DK2175851T3 (da) Biofilmbehandling
BRPI0917567A2 (pt) tratamento de doença respiratória
SE0702104L (sv) Förfarande för behandling av avfall
DK2451482T3 (da) Kombinationsterapi til behandlingen af diabetes
BRPI0907268A2 (pt) &#34;seringa de segurança&#34;
DK2330887T3 (da) Behandlingsindretning
BRPI0823131A2 (pt) Bandejas curúrgicas estéreis
DK2173831T3 (da) Brøndbehandling
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0916079A2 (pt) tratamento de água marinha residual
DE502008000740D1 (de) Rollosystem
BRPI0906606A2 (pt) Tratamento terapêutico para condições do pulmão.
DK2321359T3 (da) Fremgangsmåde til behandling af naturlige gummiprodukter
EP2106253A4 (en) TREATMENT OF ACOUPHEN
BRPI1010516A2 (pt) Métodos de tratamento de edema relacionados à isquemia-reperfusão
BRPI0806944A2 (pt) Medicamento para o tratamento de endometriose
DK3388111T3 (da) Organoarsenforbindelse til behandlingen af kræft